Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Overview
Explore Amphastar Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.3B
P/E Ratio
11.52
EPS (TTM)
$2.26
ROE
0.15%
AMPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Amphastar Pharmaceuticals, Inc. (AMPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 47.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.16.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.52 and a market capitalization of 1.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.